Breaking News, Collaborations & Alliances

Charles River, Valo Enter AI-enabled Drug Discovery Pact

Multiyear partnership will leverage Valo’s Opal Computational Platform to accelerate drug discovery and development

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

p.p1 {margin: 0.0px 0.0px 8.0px 0.0px; font: 11.0px ‘Trebuchet MS’} span.s1 {letter-spacing: 0.0px} Charles River Laboratories and Valo Health, LLC, a technology company using human-centric data and computation powered by artificial intelligence (AI) to transform the drug discovery and development process, have formed a multiyear strategic partnership. This agreement will combine Valo’s Opal Computational Platform with Charles River’s drug discovery and development capabilities ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters